Drugs / Sustanon 250
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07143279 | Feb → Nov 2026 expected | hypogonadism, male | Jules Bordet Institute | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sustanon 250 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07143279 ↗ |
| Route | Intramuscular | “Sustanon 250® (1 ml, IM) will be administered on day 0” NCT07143279 ↗ |